Skip to content
KN

Knowles Corp

Knowles Corp Q4 FY2024 earnings call

February 13, 2025 · fiscal period ended 2024-12

EPS · actual vs est

$0.27 / $0.28Miss -3.6%

Revenue · actual vs est

$142.5M / $150.5MMiss -5.3%
Ask about this call

Summary

Generated 2025-02-13

Management highlights

  • Q4 revenue of $143 million was within guided range; non-GAAP diluted EPS of $0.27 was within guided range; cash from operations of $35 million inclusive of CMM.
  • Revenue and earnings shortfall in Q4 due to plant consolidation and ramping issues in specialty film capacitor line, not lack of shippable orders.
  • 2024 continuing operations revenue grew 21% and non-GAAP diluted EPS grew 32% driven by MedTech and specialty audio strength and Cornell acquisition.
  • MedTech and specialty audio continuing to drive growth by partnering with customers and leveraging fixed overhead; Precision Device segment had acceleration in orders from Q3 in medical and defense, with distribution book-to-bill trend positive in Q4.
  • Strong cash generation; board authorized additional $150 million for share buyback; fluid tariff situation with ~5% of 2024 continuing operations revenue subject to tariffs.
View in transcript ↓

Segment performance

In Q4, MedTech and specialty audio revenue grew 9% sequentially and was flat year-over-year. 2024 revenues grew by 8% and adjusted EBIT by 13% from 2023 levels. For the Precision Device segment, Q4 revenues grew 4% year over year. Challenges with shipments in specialty film capacitor products resulted in a greater than $3 million shortfall in shipment plans. On a full-year basis, revenue for Precision Devices grew 36% compared to 2023 due to the addition of Cornell, and MedTech and specialty audio revenue grew 8% from 2023.

View in transcript ↓

Guidance

  • Q1 2025 revenues expected between $124 million and $134 million.
  • R&D expenses expected between $8 million and $9 million; selling and administrative expenses within $23 million to $25 million (down $2M Y/Y).
  • Adjusted EBIT margin for Q1 expected 16% to 18%; interest expense estimated $2M to $3M; effective tax rate 13% to 17%; EPS expected $0.16 to $0.20 per share.
  • Cash utilized in operating activities projected $15 million to $5 million; capital spending expected $4 million.
View in transcript ↓

Risks

  • Fluid tariff situation with ~5% of 2024 continuing operations revenue subject to tariffs on importing goods from China or Mexico.
  • Challenges in plant consolidation for specialty film capacitors leading to shipment shortfalls in Q4; production transfer took longer than expected, and order book had numerous new custom products ramping at once.
View in transcript ↓

Q&A highlights

Q: Anthony Stoss asked about pricing pressure across segments and inventory levels.

A: Jeffrey Niew said pricing pressure in Precision Device segment net-net is positive; $5-$6M pricing increase from Cornell acquisition expected in 2025, and ~$2-$3M more; MSA business had some pricing pressure on mature products. John Anderson clarified inventory at customers (distributors/OEMs) was 6 months at end of Q3, down to 4-4.5 months at end of Q4.

Q: Bob Labick asked about industrial end markets, specialty film products, and R&D.

A: Jeffrey Niew said industrial end markets have many smaller customers, and bookings are stabilizing; specialty film products are for pulse power applications, with a $75M+ order in energy sector starting shipments in 2026; John Anderson mentioned R&D investments in various areas including automation, HVAC, downhole pumps, semiconductor equipment

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.27$0.28-3.6%$0.28
Revenue$142.5M$150.5M-5.3%$215.2M

Transcript

February 13, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.